Patients with prostate cancer can position themselves to receive the best care possible by being seen by a multidisciplinary team of healthcare providers. When being treated for prostate cancer, ...
According to University Hospitals, Cutler Center for Men members are 37% more likely to have at least one doctor’s visit in the last year with 70% more likely to have a PSA test for prostate cancer.
En route to coaching the New England Patriots to his first career home win as New England's head coach, Mike Vrabel had some extra motivation. As revealed ahead ...
Washington is just hours away from yet another federal government shutdown, with prospects looking rather bleak for a last-minute compromise ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery - the ...
CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...
Speaking during the camp, HCG cancer resident doctor Dr Harrison Mbari and NARPOK Chairman Julius Waweru lauded the initiative, saying some retired officers were facing financial difficulties in ...
A partisan standoff over heath care and spending is threatening to trigger the first U.S. government shutdown in almost seven years, with ...
For patients with recurrent retroperitoneal sarcomas that cannot be treated surgically, treatment choices are limited. These tumors can grow quite large in the abdomen adjacent to vital organs or ...
As the New England Patriots took the field during warmups for their Week 4 matchup against the Carolina Panthers, they offered a unique sartor ...
Phase III trial presented at ASTRO in San Francisco finds five-treatment regimen poised to become new standard of care. SAN FRANCISCO, Sept. 29, 2025 ...